• Shefrin S Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, India
  • Sreelaxmi C. S. Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, India
  • Vishnu Vijayan Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, India
  • Sreeja C. Nair Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, India


Objective: To formulate and characterize midazolam loaded niosomal transdermal patches for overcoming the frequent dosing and lower bioavailability complications associated with conventional therapy.

Methods: The loaded niosomal transdermal patches were prepared by thin film hydration method. The preliminary evaluation and characterization studies was conducted to find the optimised formulation. The in vitro release and ex-vivo permeation studies were investigated. The histopathological studies and stability studies were also assessed.

Results: The midazolam loaded niosomal transdermal patches of vesicle size and zeta potential 116.1±84.46 d. nm and 8.56±1.2 mV respectively was formulated. The characterizations of both niosome and niosomal transdermal patches were found to be within the acceptable limits. The in vitro drug release showed an initial burst release followed by sustained release for both optimised niosomal formulation N5 and optimised niosomal transdermal patch formulation NT5with a maximum activity at 97.3±0.35% and 98.9±0.20% respectively. The ex vivo permeation studies of niosomal transdermal patch NT5 was performed which showed a higher permeability than control solution with a flux value of 0.151. The histopathological studies of the optimised formulation showed no detectable lesions upon skin surface and irritations. The stability studies showed that patches were stable over 90 d in different atmospheric conditions.

Conclusion: The midazolam loaded niosomal transdermal patch was found to be a promising nano drug delivery alternative which showed better entrapment, release with permeation profile for the daily management of epilepsy with decreased dosing frequency.

Keywords: Status epilepticus, Midazolam, Niosome, Soya bean oil, Niosomal transdermal patch, Gelatin


1. Suruchi S, Vaishali D. Epilepsy–a comprehensive review. Int J Pharm Res Rev 2013;2:61-80.
2. Jessica JFW, Ingrid ES, Robert SF. The new definition and classification of seizures and epilepsy. Epilepsy Res 2018;139:73-9.
3. Karthika R, Krishnapriya M, Anupriya, Nair SC. An outlook to non-pharmacological and novel approaches to combat the uncurable firing disorder. Int J Pharm Sci Rev Res 2016;40:55-61.
4. Bateman LM, Begley CE, Ben Menachem E. Overcoming barriers to successful epilepsy management. Epilepsy Curr 2012;12:158-60.
5. Yevgeny B, Yero S, Kyung-Il P, Bonnie R, Wendy P, Kimberly L, et al. Staged anticonvulsant screening for chronic epilepsy. Ann Clin Translation Neurol 2016;3:908–23.
6. Jacqueline AF, White HS, Henrik K, Gregory LH, Michael DP, Andrew JC, et al. Development of new treatment approaches for epilepsy: Unmet needs and opportunities. Epilepsia 2013;54:3-12.
7. Mark M. Recent advances in epilepsy. J Neurol 2017;264:1811-24.
8. Cui TL, Ying ZZ, Ho LW, Jun C, Lei P, Xin QT. Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomed 2014;10:2241-57.
9. Shefrin S, Sreelaxmi CS, Vishnu V, Nair SC. Enzymosomes: a rising effectual tool for targeted drug delivery system. Int J Appl Pharm 2017;9:1-9.
10. Chen DK, Fisher RS. New route for delivery of anti-epileptic medications. Acta Neurol Taiwanica 2006;15:225-31.
11. Revathy BM, Lakshmi VS, Aiswarya MU, Keerthana R, Nair SC. Porphysomes-a paradigm shift in targeted drug delivery. Int J Appl Pharm 2018;10:1-6.
12. Pravina H, Nivedita N, Sujay C. Niosome: a promising pharmaceutical drug delivery. Int J Pharm Drug Anal 2014;2:425-31.
13. Shirsand SB, Para MS, Nagendrakumar D, Kanani KM, Keerthy D. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. Int J Pharm Investig 2012;2:201-7.
14. Thagele R, Mishra, Pathak AK. Formulation and characterization of clarithromycin-based nanoparticulate drug delivery system. Int J Res Pharm Life Sci 2011;2:510–5.
15. Saeid M, Afra. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Controlled Release 2014;185:22-36.
16. Gyanendra S, Harinath D, Shailendra KS, Shubhini AS. Niosomal delivery of isoniazid–development, and characterization. Trop J Pharm Res 2011;10:203-10.
17. Ahmad U, Gihan F, Tahani EF. Performance of meloxicam niosomal gel formulations for transdermal drug delivery. Br J Pharm Res 2016;12:1-14.
18. Parika S, Nitya S, Basant S, Neha K. Development and in vitro evaluation of ambroxol hydrochloride niosome using thin film hydration method. IOSR J Pharm Biol Sci 2016;11:10-8.
19. Ramona K, Haema T. Lipid peroxidation: its effects on the formulation and pharmaceutical emulsions. Asian J Pharm Sci 2017;12:401-11.
20. Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm 2005;300:95-101.
21. Ravi G, Gupta NV. The treatment of Alzheimer's disease by using Donepezil loaded the transdermal patch. J Chem Pharm Res 2015;7:806-13.
22. Lakshmi PK, Mounika K, Saroja CH. Transdermal permeation enhancement of lamotrigine using terpenes. J Pharm Care Health Sys 2014;1:1-6.
23. Thakur V, Arora S, Prashar B, Vishal P. Niosomes and liposomes-vesicular approach towards transdermal drug delivery. Int J Pharm Chem Sci 2012;1:981-93.
24. Ahlam ZA, Maeliosa TCMc, Ryan FD. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of barrier properties of stratum corneum. Pharmaceutics 2015;4:438-70.
25. Hams AS, Lustig W, Yang L, Bozcar A, Buckheit KW, Buckheit RW. In vitro and ex vivo evaluations on transdermal delivery of HIV inhibitor IQP-0410. PLoS One 2013;8:63-70.
26. Krishnapriya M, Karthika R, Nair SC. Antiepileptic rectal hydrogel loaded with carbamazepine–rice bran wax microspheres. Asian J Pharm Clin Res 2017;10:264-70.
27. Gorle AP. A way to increase the effectiveness of paracetamol drug through transdermal patch. Int Res J Pharm 2016;7:30-4.
28. Florian L, Nesrine H, Pascal L, Emmanuel C, Ghassen B, Fillatre P, et al. Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood. Crit Care 2015;19:772-5.
29. Jithendra KP, Sudhir M, Prasad AR, Saradhi AP, Reddy ES. Dissolution profile enhancement of poorly water-soluble drug midazolam by using solid dispersion technique. Panacea J Pharm Pharm Sci 2013;1:5-10.
30. Ziyaur R, Ahmed SZ, Raghu S, Vilayat AS, Mansoor AK. Improvement of physicochemical propertries of an antiepileptic drug by salt engineering. AAPS Pharm Sci Tech 2012;13:793-801.
31. Jayashree BT, Priyanka PS, Rashmi VT, Kamlesh JW, Milind JU. Formulation and pharmacodynamic investigations of lamotrigine microspheres in pentylenetetrazole induced seizures in rats. Asian J Pharm 2017;11:215-24.
32. Lopalco A, Ali H, Denora N, Rytting E. Oxcarabmazepine loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood-brain barrier and human placental trophoblast. Int J Nanomed 2015;10:1895-996.
33. Kumar PA, Singh R, Karthick K, Arulkumaran KSG. Formulation and evaluation of sustained released niosomes containing pregabalin. Int J Res Pharm Life Sci 2013;4:2770-4.
34. Asthana GS, Asthana A, Singh D, Sharma PK. Etodolac containing topical niosomal gel: formulation development and evaluation. J Drug Delivery 2016;10:32-40.
35. Stan CD, Tataringa G, Gafitanu C, Dragan M, Braha S, Popescu MC, et al. Preparation and characterization of niosomes containing metronidazole. Farmacia 2013;61:1178-85.
36. Cherukuri S, Batchu UR, Mandava K, Cherukuri V, Ganapuram KR. Formulation and evaluation of transdermal drug delivery of Topiramate. Int J Pharma Investig 2017;7:10-7.
37. Shivhare UD, Wasnik SV. Formulation development and evaluation of niosomal gel for transdermal delivery of an antihypertensive drug. Int J Biopharm 2013;4:231-8.
38. Ali AMA, Sarhan HA, Magdy T. Preparation and characterization of phenytoin sodium niosomes for enhanced closure of skin injuries. Int J Pharm Pharm Sci 2014;6:542-6.
39. Satyavathi V, Hasanthali AA, Ilavarasan R, Sangeetha T. Formulation and evaluation of niosomal in situ gel ocular delivery systrm of Brimonidine tartrate. Int J Life Sci Pharm Res 2012;2:82-95.
40. Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 2007;328:130-41.
41. Samifar S, Akki R, Ramya MG, Naik VV. Development and characterisation of carbamazepine loaded non-ionic surfactant vesicles. Acta Chim Pharm Indica 2015;5:29-40.
42. Lopez T, Cuevas JL, Jardon G, Gomez E, Ramirez P, Novaro O, et al. Preparation and characterization of antiepileptic drug encapsulated in sol-gel titania nanoparticles as controlled release system. Med Chem 2015;10:161-72.
43. Akhtar N, Arkvanshi S, Bhattacharya SS, Verma A, Pathak K. Preparation and evaluation of buflomedil hydrochloride niosomal patch for transdermal delivery. J Liposome Res 2014;10:1-11.
44. Begum SS, Prakash PR, Jaharabee B, Reddy YD, Ravishankar V, Bhaskar NV. Preparation and evaluation of niosomes using clopidogrel bisulphate as a model. Inventi Impact NDDS 2015;4:170-7.
45. Singh G, Dwivedi H, Saraf SK, Saraf SA. Niosomal delivery of isoniazid-development and characterization. Trop J Pharm Res 2011;10:203-10.
46. Rajendran V. Effect of niosomes in the transdermal delivery of antidepressant sertraline hydrochloride. J Sci Innov Res 2016;5:138-43.
47. Rahman L, Arisanty, Manggau. Niosomal transdermal gel formulation of curcumin having an anti-inflammatory effect in experimental rat models. J Chem Pharm Res 2015;7:843-9.
48. Singh A, Bali A. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. J Anal Sci Technol 2016;7:1-13.
49. Paul A, Fathima M, Nair Sc. Intra nasal in situ gelling system of lamotrigine using ion activated mucoadhesive polymer. Open Med Chem J 2017;11:222-44.
50. Kumar KPS, Bhowmik D, Singh RK. Formulation and evaluation of ramipril transdermal patch. Indo Am J Pharm Res 2014;4:1850-6.
51. Nanda S, Saroha K, Yadav B, Sharma B. Formulation and characterization of the transdermal patch of amlodipine besylate. Int J Pharm Chem Sci 2012;1:953-69.
52. Kavitha K, Kumar DP. Development of transdermal patches of nicardipine hydrochloride: an attempt to improve bioavailability. Int J Res Pharm Biomed Sci 2010;1:113-21.
53. Bharkatiya M, Nema RK, Bhatnagar M. Development and characterization of transdermal patches of metoprolol tartrate. Asian J Pharm Clin Res 2010;3:130-4.
54. Kurakula M, Ahmed OAA, Fahmy UA, Ahmed TA. Solid lipid nanoparticles for transdermal delivery of avanafil: optimisation, formulation, in vitro and ex vivo studies. J Liposome Res 2016;26:288-96.
55. Salih OS, Samein LH, Ali WK. Formulation and in vitro evaluation of rosuvastatin calcium niosomes. Int J Pharm Pharm Sci 2013;5:525-35.
56. Mohawed OAM, Ashmoony MM, Elgazayerly ON. Niosome encapsulated clomipramine for transdermal controlled delivery. Int J Pharm Pharm Sci 2014;6:567-75.
57. Patel KK, Kumar P, Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech 2012;13:1502-10.
58. Gupta A, Singh S, Kotla NG, Webster TJ. Formulation and evaluation of a topical niosomal gel containing a combination of benzoyl peroxide and tretinoin for antiacne activity. Int J Nanomed 2015;10:171-82.
59. Thakur R, Anwer MK, Shams MS, Ali A, Khar RK, Shakeel F. Proniosomal transdermal therapeutic system of Losartan potassium: Development and Pharmacokinetic evaluation. J Drug Target 2009;17:442-9.
60. Chaudhari SP, Chatur VM. Development of valproic acid in situ gel formulation for epilepsy. Indian J Pharm Educ Res 2013;47:31-41.
61. Rajan M, Raj V. Formation and characterization of chitosan-polylactic acid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery. Carbohydr Polym 2013;98:951-98.
62. Chaw CS, Kim KYA. Effect of formulation compositions on niosomal preparations. Pharm Dev Tech 2013;18:667-72.
63. Cizinauskas V, Elie N, Brunelle A, Briedis V. Skin penetration enhancement by natural oils for dihydroquercetin delivery. Molecules 2017;22:1-16.
64. Lakshmi PK, Mounika K, Saroja CH. Transdermal permeation enhancement of lamotrigine using terpenes. J Pharma Care Health Sys 2014;1:1-6.
65. Sanjeev KP, Chandana H, Dinesh P, Pralay M. Biodegradable polymers for potential delivery systems for therapeutics. Adv Polym Sci 2013;254:169-202.
66. Paul S, Jayan A, Sasikumar CS. Physical, chemical and biological studies of gelatin/chitosan-based transdermal films with embedded silver nanoparticles. Asian Pac J Trop Dis 2015;5:975-86.
67. Wang FL, Ji HM, Zhu JY, Guan YZ, Chen YJ. Penetration enhancement effect of turpentine oil on transdermal film of Ketorolac. Trop J Pharm Res 2015;14:1341-8.
68. Honary S, Zahir F. Effect of zeta potential on the properties of nano-drug delivery systems–a review (Part 1). Trop J Pharm Res 2013;12:255-64.
69. Nair SC, Anoop KR. Local antimicrobial delivery of satranidazole loaded cross-linked periodontal chips using bio degradable polymers. Int J Pharm Pharm Sci 2013;5:839-47.
70. Sambhakar S, Paliwal S, Sharma S, Singh B. Formulation of risperidone loaded proniosomes for effective transdermal delivery: an in vitro and in vivo study. Bull Fac Pharm Cairo Univ 2017;55:239-47.
71. Jacob S, Nair AB, Al-Dhubiab BE. Preparation and evaluation of niosomal gel containing acyclovir for enhanced dermal deposition. J Liposome Res 2017;27:283-92.
72. Lu Z, Yeh TK, Tsai M, Au JL, Weintjes MG. Paclitaxel-loaded gelatin nanoparticles for intravesial bladder cancer therapy. Clin Cancer Res 2004;10:7677-84.
73. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flubiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 2008;361:104-11.
74. Bansal S, Aggarwal G, Chandel P, Harikumar SL. Design and development of cefdinir niosomes for oral delivery. J Pharm Bioallied Sci 2013;5:318-25.
75. Jain SK, Chourasia MK, Sabitha M, Jain R, Jain AK, Ashawat M, et al. Development and characterisation of transdermal drug delivery systems for diltiazem hydrochloride. J Drug Delivery 2003;10:169-77.
76. Aswathy SN, Vidhya KM, Saranya TR, Sreelakshmy KR, Nair SC. Mucoadhesive buccal patch of cefixime trihydrate using biodegradable natural polymer. Int J Pharm Pharm Sci 2014;6:366-71.
77. Jithendra B, Subhash P, Pathak AK. Development and optimisation of transdermal systems of lisinopril dehydrate: employing permeation enhancers. Iran J Pharm Sci 2010;6:245-51.
78. Subramanian K, Indumathi S, Vijayakumar V. Fabrication and evaluation of chitosan-gelatin composite film as a drug carrier for in vitro transdermal delivery. Int J Pharm Sci Res 2014;5:438-47.
79. Mutalik S, Udupa N. Glibenclamide transdermal patches: physicochemical, pharmacodynamics and pharmacokinetic evaluations. J Pharm Sci 2004;93:1577–94.
80. Ataurrahman F, Rasale, Ansari H. Formulation, development evaluation of flexible polymeric topical antifungal film (TAF). Int J Adv Pharm Med Bioallied Sci 2015;3:137-41.
81. Yousuf M, Ahmad M. Ketotifan fumarate and Salbutamol sulphate combined transdermal patch formulations: in vitro release and ex vivo permeation studies. Indain J Pharm Sci 2013;75:569-77.
82. Foox M, Zilberman M. Drug delivery from gelatin-based systems. Expert Opin Drug Delivery 2015;12:1547-63.
83. Abdelbary GA, Aburahma MH. Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental pain. J Liposome Res 2013;25:107-21.
84. Narayanan D, MGG HL, Koyakutty M, Nair S, Menon D. Poly-(ethylene glycol) modified gelatin nanoparticles for sustained delivery of the anti-inflammatory drug Ibuprofen-Sodium: an in vitro and in vivo analysis. Nanomedicine 2013;9:818-28.
85. Tanwar YS. Formulation and evaluation of transdermal films of salbutamol sulphate. Dhaka Univ J Pharm Sci 2005;4:93–7.
86. Panchagnula R, Desu H, Jain A, Khandavilli S. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate, role of solubility, partitioning and lipid bilayer perturbation. Farmaco 2005;60:894–9.
87. Cocera M, Lopez O, Coderch L, Parra JL, de la Maza A. Permeability investigations of phospholipids liposomes by adding cholesterol. Colloids Surf A 2003;221:9-17.
88. Bajpai AK, Choubey J. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J Mater Sci Mater Med 2006;17:345-58.
89. Zhang K, Zhang Y, Li Z, Li N, Feng N. Essential oil-mediated glycerosomes increase transdermal paeoniflorin delivery: optimization, characterization, and evaluation in vitro and in vivo. Int J Nanomed 2017;12:3521-32.
90. Castaneda PS, Chavez JJE, Aguado AT, Cruz IMR, Contreras LMM. Design and evaluation of transdermal patch with atorvastatin. Farmacia 2017;65:908-16.
91. Abd E, Yousef SA, Pastore MN, Telaprolu K, Mohammed YH, Namjoshi S, et al. Skin models for the testing of transdermal drugs. Clin Pharmacol 2016;8:163-76.
92. Sabitha M, NS Rejinold, Amrita N, Vinoth KL, Shantikumar VN, Rangasamy J. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale 2012;4:239-50.
93. Ridy MSE, Yehia SA, Mohsen AM, Awdan SAE, Darwish AB. Preparation, characterisation and in vivo evaluation of Span60Lornoxicam niosomes. Res J Pharm Biol Chem Sci 2017;8:398-411.
94. Shinde UA, Kanojiya SS. Serratiopeptidase niosomal gel with potential in topical delivery. J Pharm 2014;10:295-382.
95. Mohawed OA, Ashmoony MME, Elgazayerly ON. Niosome encapsulated clopirmine for transdermal controlled delivery. Int J Pharm Pharm Sci 2014;6:567-75.
40 Views | 37 Downloads
How to Cite
S, S., S., S. C., Vijayan, V., & Nair, S. C. (2019). ANTI-EPILEPTIC DRUG LOADED NIOSOMAL TRANSDERMAL PATCH FOR ENHANCED SKIN PERMEATION. International Journal of Applied Pharmaceutics, 11(2), 31-43.
Original Article(s)

Most read articles by the same author(s)